We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Medical Solutn | LSE:MLS | London | Ordinary Share | GB0009739649 | ORD 2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.72 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
For further information, please contact:
Medical Solutions plc
Nick Ash
Managing Director
Tel: 0115 973 9010
www.medical-solutions.co.uk
Bishopsgate Communications Ltd
Nick Rome/Gemma O'Hara
Tel: 0207 562 3350
www.bishopsgatecommunications.com
4 March 2008
Medical Solutions plc
("Medical Solutions" or "the Company")
NOTICE OF RESULTS
Medical Solutions plc, (LSE: MLS), the provider of expert, quality services and
products to the healthcare, pharma biotech and life sciences research sectors,
expects to announce its preliminary results for the year ended 31 December 2007
on 17 March 2008.
- ENDS -
About Medical Solutions
Medical Solutions plc (LSE: MLS) is a leading provider of expert, quality
services and products to the healthcare, pharma biotech and life science
research sectors. Its Healthcare operations provide screening and reference
laboratory diagnostic testing for cancer and other diseases and additional
predictive testing for treatment optimisation for clinicians and patients.
Pharma Biotech Services offers support for early stage therapeutic development,
offering a 'one-stop shop' from tissue pathology, immunohistochemistry,
sophisticated image analysis, biomarker determination and assay development to
pharmacogenomics including genotyping and gene expression analysis. The Life
Science Research services provide core laboratory research support from
conceptualization to implementation, calling upon a wide range of cutting-edge
technology platforms including an online catalogue of biomolecular tools. This
incorporates DNA sequencing, whole genome amplification and a comprehensive
library of genomic reagents and clones including cDNA and RNAi.
The group has its headquarters in Nottingham, UK where it operates state of the
art reference laboratory facilities, with additional UK laboratory facilities
in Cambridge and Oxford. Medical Solutions is CPA and GLP accredited and is
licensed by the Human Tissue Authority.
END
1 Year Medical Solutions Chart |
1 Month Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
